• OPEN AN ACCOUNT
Indian Indices
Nifty
24,971.90 -140.50
(-0.56%)
Sensex
82,893.66 996.87
( 1.22%)
Bank Nifty
56,059.35 -193.50
( -0.34%)
Nifty IT
38,414.10 -577.35
( -1.48%)
Global Indices
Nasdaq
42,601.30 373.47
(0.88%)
Dow Jones
6,045.90 57.06
(0.95%)
Hang Seng
38,330.35 -72.88
(-0.19%)
Nikkei 225
8,758.04 -16.61
(-0.19%)
Forex
USD-INR
86.50 -0.18
(-0.20%)
EUR-INR
99.61 0.16
(0.17%)
GBP-INR
116.27 -0.12
(-0.11%)
JPY-INR
0.59 0.00
(-0.73%)

EQUITY - MARKET SCREENER

Jubilant Pharmova Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
530019
INE700A01033
145.519774
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
JUBLPHARMA
0
17867.88
EPS(TTM)
Face Value()
Div & Yield %
1.54
1
0.44
 

NCL Research and Financial Services standalone net profit declines 58.33% in the March 2025 quarter
Jun 01,2025
Net profit of NCL Research and Financial Services declined 58.33% to Rs 0.10 crore in the quarter ended March 2025 as against Rs 0.24 crore during the previous quarter ended March 2024. Sales declined 71.94% to Rs 2.02 crore in the quarter ended March 2025 as against Rs 7.20 crore during the previous quarter ended March 2024.

For the full year,net loss reported to Rs 1.36 crore in the year ended March 2025 as against net profit of Rs 1.61 crore during the previous year ended March 2024. Sales declined 20.21% to Rs 8.53 crore in the year ended March 2025 as against Rs 10.69 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales2.027.20 -72 8.5310.69 -20
OPM %37.62-14.17 --8.6810.20 -
PBDT0.140.18 -22 -0.602.03 PL
PBT0.120.16 -25 -0.661.98 PL
NP0.100.24 -58 -1.361.61 PL